mission
OUR MISSION
Vita Genomics commits to provide the most comprehensive services in personalized medicine and build the R&D technology platform in genomics, which is comparable to the ones of biotechnology companies in United States and Europe.
We successfully integrated the laboratory medicine market and hence Vita Genomics is geared to become the largest laboratory medicine group in Taiwan. Furthermore, we will acquire more clinical laboratories, build bridges with large domestic hospitals, and target customers in the executive health examination arena.
We will maximize the number of international pharmaceutical partners and race to develop new drugs and their companion tests. In the long run, Vita Genomics will aim at integrating the biotechnology industry vertically and horizontally.
Taiwan’s Largest Genomic/Laboratory Medicine Group
Vita Genomics builds up a flood of domestic clinical resources, including the Tri-Service General Hospital, Academia Sinica, China Medicine University, the National Taiwan University Hospital, the Taipei Veterans General Hospital, the National Cheng Kung University Hospital, Show Chwan Health Care System, Chang Gung Medical System, Kaohsiung Medical University, and so on.
Additionally, Vita Genomics vertically integrates the genomic/laboratory medical market and provide a full range of services including:
Development of Six Genomic Technology Platforms Based on the Exclusive SNP Database in Asians
Vita Genomics possesses a professional and technical team that focuses on a variety of human genome research projects and tailor-made tests. With the buttress of six major genomic technology platforms, Vita Genomics has received considerable attention from multinational pharmaceutical companies for collaboration, such as:
In addition to the continued efforts of integrating its self-owned technology platforms, Vita Genomics combines the exclusive databases, takes steps in clinical applications, and provides our pharmaceutical partners with the following services:.
Vita Genomics commits to provide the most comprehensive services in personalized medicine and build the R&D technology platform in genomics, which is comparable to the ones of biotechnology companies in United States and Europe.
We successfully integrated the laboratory medicine market and hence Vita Genomics is geared to become the largest laboratory medicine group in Taiwan. Furthermore, we will acquire more clinical laboratories, build bridges with large domestic hospitals, and target customers in the executive health examination arena.
We will maximize the number of international pharmaceutical partners and race to develop new drugs and their companion tests. In the long run, Vita Genomics will aim at integrating the biotechnology industry vertically and horizontally.
Taiwan’s Largest Genomic/Laboratory Medicine Group
Vita Genomics builds up a flood of domestic clinical resources, including the Tri-Service General Hospital, Academia Sinica, China Medicine University, the National Taiwan University Hospital, the Taipei Veterans General Hospital, the National Cheng Kung University Hospital, Show Chwan Health Care System, Chang Gung Medical System, Kaohsiung Medical University, and so on.
Additionally, Vita Genomics vertically integrates the genomic/laboratory medical market and provide a full range of services including:
- Devices, Tests, and Reagents
- Testing Services in Clinics and Hospitals
- Exclusive Market
- Foreign Agent
- Health Insurance and Self-Pay Market
Development of Six Genomic Technology Platforms Based on the Exclusive SNP Database in Asians
Vita Genomics possesses a professional and technical team that focuses on a variety of human genome research projects and tailor-made tests. With the buttress of six major genomic technology platforms, Vita Genomics has received considerable attention from multinational pharmaceutical companies for collaboration, such as:
- Signed a collaboration agreement for gene chip development with Affymetrix, a gene chip company.
- Signed sCRO contracts with the world renowned top ten pharmaceutical companies.
In addition to the continued efforts of integrating its self-owned technology platforms, Vita Genomics combines the exclusive databases, takes steps in clinical applications, and provides our pharmaceutical partners with the following services:.
- sCRO
- Genome Sequencing
- NGS